PDF herunterladen
Geburtshilfe Frauenheilkd 2024; 84(03): 233-240
DOI: 10.1055/a-2162-6004
GebFra Magazin
Aktuell diskutiert

Migräne in speziellen hormonellen Situationen

Sabine Segerer
1   amedes MVZ Hamburg, Hamburg
,
Stefan Evers
2   Klinik für Neurologie, Krankenhaus Lindenbrunn, Coppenbrügge
3   Medizinische Fakultät, Universität Münster, Münster
,
Heike Israel-Willner
4   Neurologisches Facharztzentrum Berlin, Berlin
,
Bianca Raffaelli
5   Klinik für Neurologie, Charité – Universitätsmedizin Berlin, Berlin
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Welche Therapieoptionen gibt es bei menstrueller Migräne? Wie hilft man Patientinnen, die sowohl an Endometriose als auch an Migräne erkrankt sind, am besten? Was ist bei einer hormonellen Transition zu beachten? Der Beitrag gibt Empfehlungen zu Therapie und Prophylaxe.

Publikationsverlauf

Artikel online veröffentlicht:
06. März 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Victor TW, Hu X, Campbell JC. et al. Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia 2010; 30: 1065-1072
    CrossrefPubMedSuche in Google Scholar
  • 2 Abu-Arafeh I, Razak S, Sivaraman B. et al. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol 2010; 52: 1088-1097
    CrossrefPubMedSuche in Google Scholar
  • 3 Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis – part I. Headache 2006; 46: 3-23
    CrossrefPubMedSuche in Google Scholar
  • 4 Böttcher B, Kyprianou A, Lechner C. et al. Manifestation of migraine in adolescents: Does it change in puberty?. Eur J Paediatr Neurol 2020; 26: 29-33
    CrossrefPubMedSuche in Google Scholar
  • 5 Silberstein SD. The role of sex hormones in headache. Neurology 1992; 42: 37-42
    PubMedSuche in Google Scholar
  • 6 Welch KM. Migraine and ovarian steroid hormones. Cephalalgia 1997; 17 (Suppl. 20) 12-16
    CrossrefPubMedSuche in Google Scholar
  • 7 MacGregor EA, Victor TW, Hu X. et al. Characteristics of menstrual vs. nonmenstrual migraine: a post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial. Headache 2010; 50: 528-538
    CrossrefPubMedSuche in Google Scholar
  • 8 Kim M, Blanchard EB. Two studies of the non-pharmacological treatment of menstrually-related migraine headaches. Headache 1992; 32: 197-202
    CrossrefPubMedSuche in Google Scholar
  • 9 de Lignieres B, Vincens M, Mauvais-Jarvis P. et al. Prevention of menstrual migraine by percutaneous oestradiol. Br Med J (Clin Res Ed) 1986; 293: 1540
    CrossrefPubMedSuche in Google Scholar
  • 10 Dennerstein L, Morse C, Burrows G. et al. Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol 1988; 2: 113-120
    CrossrefPubMedSuche in Google Scholar
  • 11 Smits MG, van der Meer YG, Pfeil JP. et al. Perimenstrual migraine: effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test. Headache 1994; 34: 103-106
    CrossrefPubMedSuche in Google Scholar
  • 12 Murray SC, Muse KN. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and “addback” therapy. Fertil Steril 1997; 67: 390-393
    CrossrefPubMedSuche in Google Scholar
  • 13 Martin V, Wernke S, Mandell K. et al. Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache 2003; 43: 309-321
    CrossrefPubMedSuche in Google Scholar
  • 14 Facchinetti F, Bonellie G, Kangasniemi P. et al. The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. The Sumatriptan Menstrual Migraine Study Group. Obstet Gynecol 1995; 86: 911-916
    CrossrefPubMedSuche in Google Scholar
  • 15 Solbach MP, Waymer RS. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan. Obstet Gynecol 1993; 82: 769-772
    PubMedSuche in Google Scholar
  • 16 Gross M, Barrie M, Bates D. et al. The efficacy of sumatriptan in menstrual migraine. Eur J Neurol 1995; 2: 144-145
    PubMedSuche in Google Scholar
  • 17 Savi L, Omboni S, Lisotto C. et al. Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan. J Headache Pain 2011; 12: 609-615
    CrossrefPubMedSuche in Google Scholar
  • 18 Bartolini M, Giamberardino MA, Lisotto C. et al. Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study. J Headache Pain 2012; 13: 401-406
    CrossrefPubMedSuche in Google Scholar
  • 19 Cady RK, Diamond ML, Diamond MP. et al. Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes. Headache 2011; 51: 664-673
    CrossrefPubMedSuche in Google Scholar
  • 20 Mannix LK, Savani N, Landy S. et al. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies. Headache 2007; 47: 1037-1049
    CrossrefPubMedSuche in Google Scholar
  • 21 Allais G, Bussone G, Tullo V. et al. Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial. Cephalalgia 2015; 35: 45-50
    CrossrefPubMedSuche in Google Scholar
  • 22 Bigal M, Sheftell F, Tepper S. et al. A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine. Headache 2008; 48: 1286-1293
    CrossrefPubMedSuche in Google Scholar
  • 23 Mathew NT. Cyclic prophylactic treatment of menstrual migraine using naproxen and ergotamine. Headache 1986; 26: 314
    PubMedSuche in Google Scholar
  • 24 Sances G, Martignoni E, Fioroni L. et al. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache 1990; 30: 705-709
    CrossrefPubMedSuche in Google Scholar
  • 25 Facchinetti F, Sances G, Borella P. et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991; 31: 298-301
    CrossrefPubMedSuche in Google Scholar
  • 26 Brandes JL, Poole A, Kallela M. et al. Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks. Cephalalgia 2009; 29: 1133-1148
    CrossrefPubMedSuche in Google Scholar
  • 27 MacGregor EA, Brandes JL, Silberstein S. et al. Safety and tolerability of short-term preventive frovatriptan: a combined analysis. Headache 2009; 49: 1298-1314
    CrossrefPubMedSuche in Google Scholar
  • 28 Moschiano F, Allais G, Grazzi L. et al. Naratriptan in the short-term prophylaxis of pure menstrual migraine. Neurol Sci 2005; 26 (Suppl. 2) s162-s166
    CrossrefPubMedSuche in Google Scholar
  • 29 Newman L, Mannix LK, Landy S. et al. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache 2001; 41: 248-256
    CrossrefPubMedSuche in Google Scholar
  • 30 Silberstein SD, Berner T, Tobin J. et al. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation. Headache 2009; 49: 1283-1297
    CrossrefPubMedSuche in Google Scholar
  • 31 Silberstein SD, Elkind AH, Schreiber C. et al. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 2004; 63: 261-269
    CrossrefPubMedSuche in Google Scholar
  • 32 Brandes JL, Smith T, Diamond M. et al. Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine. Headache 2007; 47: 886-894
    CrossrefPubMedSuche in Google Scholar
  • 33 Tuchman MM, Hee A, Emeribe U. et al. Oral zolmitriptan in the shortterm prevention of menstrual migraine: a randomized, placebo-controlled study. CNS Drugs 2008; 22: 877-886
    CrossrefPubMedSuche in Google Scholar
  • 34 Pringsheim T, Davenport WJ, Dodick D. Acute treatment and prevention of menstrually related migraine headache: evidence-based review. Neurology 2008; 70: 1555-1563
    CrossrefPubMedSuche in Google Scholar
  • 35 MacGregor EA, Frith A, Ellis J. et al. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 2006; 67: 2159-2163
    CrossrefPubMedSuche in Google Scholar
  • 36 Smits MG, van der Meer YG, Pfeil JP. et al. Perimenstrual migraine: effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test. Headache 1994; 34: 103-106
    CrossrefPubMedSuche in Google Scholar
  • 37 Pfaffenrath V. Efficacy and safety of percutaneous estradiol vs. placebo in menstrual migraine. Cephalalgia 1993; 13 (Suppl. 13) 244
    PubMedSuche in Google Scholar
  • 38 Pradalier A, Vincent D, Beaulieu P. et al. Correlation between Oestradiol Plasma Level and therapeutic Effect on menstrual Migraine. In: Clifford Rose F. ed. New Advances in Headache Research. Vol 4. London: Smith-Gordon; 1994: 129-132
    Suche in Google Scholar
  • 39 Almén-Christensson A, Hammar M, Lindh-Åstrand L. et al. Prevention of menstrual migraine with perimenstrual transdermal 17-β-estradiol: a randomized, placebo-controlled, double-blind crossover study. Fertil Steril 2011; 96: 498-500.e1
    CrossrefPubMedSuche in Google Scholar
  • 40 Magos AL, Zilkha KJ, Studd JW. Treatment of menstrual migraine by oestradiol implants. J Neurol Neurosurg Psychiatry 1983; 46: 1044-1046
    CrossrefPubMedSuche in Google Scholar
  • 41 Ornello R, Frattale I, Caponnetto V. et al. Menstrual Headache in Women with Chronic Migraine Treated with Erenumab: An Observational Case Series. Brain Sci 2021;
    CrossrefPubMedSuche in Google Scholar
  • 42 Nelles G, Schmitt L, Humbert T. et al. Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting. J Headache Pain 2010; 11: 33-44
    CrossrefPubMedSuche in Google Scholar
  • 43 Pavlovic JM, Paemeleire K, Göbel H. et al. Efficacy and safety of erenumab in women with a history of menstrual migraine. J Headache Pain 2020; 21: 95
    CrossrefPubMedSuche in Google Scholar
  • 44 Reid RL, Fortier MP, Smith L. et al. Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada. Contraception 2010; 82: 497-502
    CrossrefPubMedSuche in Google Scholar
  • 45 Teichmann A, Apter D, Emerich J. et al. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial. Contraception 2009; 80: 504-511
    CrossrefPubMedSuche in Google Scholar
  • 46 Coffee AL, Sulak PJ, Kuehl TJ. Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen. Contraception 2007; 75: 444-449
    CrossrefPubMedSuche in Google Scholar
  • 47 Sulak P, Willis S, Kuehl T. et al. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 2007; 47: 27-37
    CrossrefPubMedSuche in Google Scholar
  • 48 Lichten EM, Bennett RS, Whitty AJ. et al. Efficacy of danazol in the control of hormonal migraine. J Reprod Med 1991; 36: 419-424
    PubMedSuche in Google Scholar
  • 49 OʼDea JP, Davis EH. Tamoxifen in the treatment of menstrual migraine. Neurology 1990; 40: 1470-1471
    CrossrefPubMedSuche in Google Scholar
  • 50 Bulun SE. Endometriosis. N Engl J Med 2009; 360: 268-279
    CrossrefPubMedSuche in Google Scholar
  • 51 Simoens S, Dunselman G, Dirksen C. et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod 2012; 27: 1292-1299
    CrossrefPubMedSuche in Google Scholar
  • 52 Ferrero S, Pretta S, Bertoldi S. et al. Increased frequency of migraine among women with endometriosis. Hum Reprod 2004; 19: 2927-2932
    CrossrefPubMedSuche in Google Scholar
  • 53 Tietjen GE, Conway A, Utley C. et al. Migraine is associated with menorrhagia and endometriosis. Headache 2006; 46: 422-428
    CrossrefPubMedSuche in Google Scholar
  • 54 Adewuyi EO, Sapkota Y. International Endogene Consortium Iec. et al. Shared Molecular Genetic Mechanisms Underlie Endometriosis and Migraine Comorbidity. Genes (Basel) 2020; 11: 268
    CrossrefPubMedSuche in Google Scholar
  • 55 Gupta D, Hull ML, Fraser I. et al. Endometrial biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2016; (04) CD012165
    CrossrefPubMedSuche in Google Scholar
  • 56 Yan D, Liu X, Guo SW. Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis. Sci Rep 2019; 9: 2698
    CrossrefPubMedSuche in Google Scholar
  • 57 Raffaelli B, Overeem LH, Mecklenburg J. et al. Plasma calcitonin gene-related peptide (CGRP) in migraine and endometriosis during the menstrual cycle. Ann Clin Transl Neurol 2021; 8: 1251-1259
    CrossrefPubMedSuche in Google Scholar
  • 58 Aloisi AM, Bachiocco V, Costantino A. et al. Cross-sex hormone administration changes pain in transsexual women and men. Pain 2007; 132 (Suppl. 1) S60-S67
    CrossrefPubMedSuche in Google Scholar
  • 59 Hranilovich JA, Kaiser EA, Pace A. et al. Headache in transgender and gender-diverse patients: A narrative review. Headache 2021; 61: 1040-1050
    CrossrefPubMedSuche in Google Scholar
  • 60 Pringsheim T, Gooren L. Migraine prevalence in male to female transsexuals on hormone therapy. Neurology 2004; 63: 593-594
    CrossrefPubMedSuche in Google Scholar
  • 61 Yalinay Dikmen P, Ertas M, Kosak S. et al. Primary headaches among gender dysphoric female-to-male individuals: A cross-sectional survey on gender transition experience. Headache 2021; 61: 1194-1206
    CrossrefPubMedSuche in Google Scholar
  • 62 Nguyen HV, Gilbert AL, Fortin E. et al. Elevated Intracranial Pressure Associated With Exogenous Hormonal Therapy Used for Gender Affirmation. J Neuroophthalmol 2021; 41: 217-223
    CrossrefPubMedSuche in Google Scholar
  • 63 Sacco S, Ricci S, Degan D. et al. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain 2012; 13: 177-189
    CrossrefPubMedSuche in Google Scholar
  • 64 Diener HC, Gaul C, Kropp P. Therapie der Migräneattacke und Prophylaxe der Migräne, S1-Leitlinie, 2018. In: Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. Zugriff am 05. Mai 2023 unter: http://www.dgn.org/leitlinien
  • 65 Aegidius K, Zwart JA, Hagen K. et al. Oral contraceptives and increased headache prevalence: the Head-HUNT Study. Neurology 2006; 66: 349-353
    CrossrefPubMedSuche in Google Scholar
  • 66 Nappi RE, Terreno E, Sances G. et al. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2 V/DNG) in women with menstrually-related migraine (MRM). Contraception 2013; 88: 369-375
    CrossrefPubMedSuche in Google Scholar
  • 67 Sulak PJ, Willis SA, Kuehl TJ. et al. Headaches and Oral Contraceptives: Impact of Eliminating the Standard 7-Day Placebo Interval. Headache 2007; 47: 27-37
    CrossrefPubMedSuche in Google Scholar
  • 68 Morotti M, Remorgida V, Venturini PL. et al. Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura. Eur J Obstet Gynecol Reprod Biol 2014; 179: 63-68
    CrossrefPubMedSuche in Google Scholar
  • 69 Nappi RE, Merki-Feld GS, Terreno E. et al. Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?. J Headache Pain 2013; 14: 66
    CrossrefPubMedSuche in Google Scholar
  • 70 Somerville BW. The role of progesterone in menstrual migraine. Neurology 1971; 21: 853-859
    CrossrefPubMedSuche in Google Scholar
  • 71 Sacco S, Merki-Feld GS, Ægidius KL. et al. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain 2017; 18: 108
    CrossrefPubMedSuche in Google Scholar
  • 72 Burch R. Epidemiology and Treatment of Menstrual Migraine and Migraine During Pregnancy and Lactation: A Narrative Review. Headache 2020; 60: 200-216
    CrossrefPubMedSuche in Google Scholar